Filing Details
- Accession Number:
- 0001209191-18-047214
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-16 19:31:52
- Reporting Period:
- 2018-08-14
- Accepted Time:
- 2018-08-16 19:31:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591213 | A Paul Foster | C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-14 | 15,496 | $11.05 | 20,448 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-14 | 15,496 | $41.11 | 4,952 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-08-15 | 106 | $11.05 | 5,058 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-15 | 106 | $41.10 | 4,952 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-08-16 | 20,739 | $11.05 | 25,691 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-16 | 20,739 | $41.10 | 4,952 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-08-14 | 15,496 | $0.00 | 15,496 | $11.05 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-08-15 | 106 | $0.00 | 106 | $11.05 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-08-16 | 20,739 | $0.00 | 20,739 | $11.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 74,504 | 2024-02-20 | No | 4 | M | Direct | |
| 74,398 | 2024-02-20 | No | 4 | M | Direct | |
| 53,659 | 2024-02-20 | No | 4 | M | Direct |
Footnotes
- Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,207 shares of Common Stock acquired on June 10, 2015, 1,212 shares of Common Stock acquired on December 10, 2015 and 114 shares of Common Stock acquired on June 9, 2018.
- The weighted average sale price for the transaction reported was $41.1061, and the range of prices were between $41.10 and $41.120. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- The stock option is fully vested.
Billionaire Hedge Funds
